In sixth grade, I had 21 excused absences from school. I wasn't playing hooky like some of my teachers might've thought. I ...

New effective medications specifically designed for migraine have changed the outlook for many patients of this often misunderstood neurological disorder, experts say.

This article was originally published on Cannabis.net and appears here with permission. Migraine sufferers drop prescription drugs at record pace and switch to cannabis for headache pain!

Roughly 80% of people with migraine experience a postdrome phase, or “ migraine hangover .” During an attack, your brain goes ...

Here we go with acid reflux medications, again. First, it was their connection to dementia. Then, a connection to ...

AbbVie (NYSE: ABBV) announced today that Health Canada has approved QULIPTA (atogepant) for the prevention of migraine in adults who have at least four migraine days per month.1 QULIPTA is the first ...

In a retrospective, cross-sectional study, researchers identified the characteristics and assessed the prevalence of menstrual migraine in women.

By Colin Kellaher AEON Biopharma shares lost more than half of their value and hit a new all-time low after the clinical-stage biopharmaceutical ...

Some health disorders appear at higher rates among those with bipolar — and migraine is one of them. Luckily, certain treatments can help both. Getty ...

Axsome Therapeutics develops treatments for CNS conditions, offering two commercial products and a diverse pipeline.

Recently, the staff at the North Port Family Medicine Clinic in Muscatine have been able to offer a new Botox injection ...

QULIPTA is now the first and only oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) approved to prevent migraine across all frequencies, including episodic and chronic. Expanded ...